1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Injectables Market to 2020

Autoimmune Injectables Market to 2020

  • June 2014
  • -
  • Greystone Research Associates

In spite of the growing understanding of the underlying disease mechanisms for a host of diseases and disease families, autoimmune conditions continue to be intractable to most therapies and difficult to treat. Because of the individual genetic variability underlying the incidence and severity of autoimmune symptoms, regional variations in the market for autoimmune therapeutics can be significant. This variability is compounded by differences in treatment protocols and cultural factors, which combine to make alliance partnerships with regional players of increasing importance. Over the past two years the introduction of new and improved injectables for treating autoimmune diseases is creating new options for clinicians and patients. This optimism is being reinforced by pipeline candidates that will further the effort to improve treatment protocols for patients.

Highlights

- Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential

- Assesses existing and evolving immune disease mechanisms, treatment strategies and pipeline drug candidates

- Provides data and forecasts for major autoimmune disease segments to 2020

- Evaluates regional and global opportunities for autoimmune therapeutics

Table Of Contents

Autoimmune Injectables Market to 2020
Executive Summary

Immune Modulation in Disease Therapeutics

Evolving Models of Disease and Human Health
The Immune Response in Disease Incidence, Treatment and Prevention
The Immune Cascade
Receptors, Ligands and Cell Signaling Pathways

Autoimmune Disease Therapeutics- Commercial Realities

FDA-Approved Drugs
Patient and Disease Demographics
Competitive Landscape
Factors Limiting Growth
Regulatory Factors
Cost per Dose and Managed Care
Side Effects, Black Box Warnings and Patient Compliance

Autoimmune Disease Therapeutics - Disease Segment Analysis

Arthritis
Psoriasis
Multiple Sclerosis
Crohn's Disease
Lupus

Autoimmune Injectables - Indications, Market Data and Forecasts

TNF
Growth Factor inhibitors
Interleukins
Interferons
T-Cell Receptor Inhibitors
Innate Immune Cell Receptor Inhibitors
B-Cell Receptor Inhibitors
Kinase Inhibitors
Co-stimulator Inhibitors
Chemokine Receptors
Transcription Factors
Vascular Adhesion Inhibitors
Toll-like Receptors
Other Immune Factor Drug Candidates

Business Factors

Regulatory Factors
Clinical Trial Protocols and Endpoints
Alliances and Partnerships

Autoimmune Injectables- Company Profile

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Scleroderma Diagnostics and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Scleroderma Diagnostics and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Scleroderma Diagnostics and Therapeutics Market: Overview Scleroderma, a very rare autoimmune disorder of the skin, is a term coined from the Greek words “sklerosis,” which means hardness, and ...

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

U.S. In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market (Ankylosing Spondylitis, Alopecia Areata, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Psoriasis) By Technology Report, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The U.S. IVD for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach a value of USD 4.74 billion by 2024 .The U.S. Laboratory Developed Test (LDT) for autoimmune diseases ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.